Global Latanoprost Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Latanoprost Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Latanoprost report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Latanoprost market is projected to reach US$ 1603.1 million in 2034, increasing from US$ 1374.1 million in 2022, with the CAGR of 2.2% during the period of 2024 to 2034. Demand from Open-angle Glaucoma and Close-angle Glaucoma are the major drivers for the industry.
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Latanoprost market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Segment by Type
Brand Drug
Generic Drug
Open-angle Glaucoma
Close-angle Glaucoma
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Latanoprost market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Latanoprost, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Latanoprost industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Latanoprost in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Latanoprost introduction, etc. Latanoprost Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Latanoprost market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Latanoprost report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Latanoprost market is projected to reach US$ 1603.1 million in 2034, increasing from US$ 1374.1 million in 2022, with the CAGR of 2.2% during the period of 2024 to 2034. Demand from Open-angle Glaucoma and Close-angle Glaucoma are the major drivers for the industry.
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Latanoprost market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Segment by Type
Brand Drug
Generic Drug
Segment by Application
Open-angle Glaucoma
Close-angle Glaucoma
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Latanoprost market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Latanoprost, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Latanoprost industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Latanoprost in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Latanoprost introduction, etc. Latanoprost Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Latanoprost market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices